Saccharomyces boulardii

Therapeutic indications

Saccharomyces boulardii is indicated for:

Prevention and treatment of diarrhea

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Saccharomyces boulardii CNCM I-745 is indicated for the prevention and treatment of diarrhea of different etiologies in adults and children, such as:

  • treatment of acute infectious diarrhea of adults and children;
  • prevention and treatment of antibiotic-associated colitis and diarrhea;
  • addition to vancomycine/metronidazole treatment to prevent recurrence of Clostridium difficile diseases;
  • prevention of tube-feeding associated diarrhea.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Saccharomyces boulardii is contraindicated in the following cases:

Immunosuppression

Immunodeficiency

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: BIOFLOR Powder for oral suspension
Summary of Product Characteristics (SPC) 2021: BIOFLOR Capsule, hard
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈